One course versus two courses of recombinant alpha interferon in chronic C hepatitis.
暂无分享,去创建一个
C. Furlan | C. de Bac | G. Taliani | R. Lecce | F. Duca | C. Clementi | F. Grimaldi | M. Manganaro
[1] C. Furlan,et al. Antibodies to hepatitis C virus and response to interferon treatment in non-A, non-B chronic hepatitis. , 1991, Journal of hepatology.
[2] P. van Eyken,et al. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. , 1990, Journal of hepatology.
[3] Eugene R. Schiff,et al. Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .
[4] S. Banks,et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.
[5] H. Thomas,et al. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis. , 1989, BMJ.
[6] J. Hoofnagle,et al. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. , 1986, The New England journal of medicine.
[7] G. Mazzucco,et al. A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis. , 1990, Journal of hepatology.
[8] J. Deimer,et al. One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b. , 1990, Journal of hepatology.
[9] A. Moreno,et al. Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control group , 1990 .